This Senate resolution designates the first week of April as National Asbestos Awareness Week to raise public awareness about the dangers of asbestos exposure. The bill does not create new laws or regulations but instead calls for the Surgeon General to educate the public about asbestos-related health risks. It highlights that asbestos fibers can cause serious diseases like mesothelioma and asbestosis, particularly affecting workers and residents of older buildings constructed before 1975. The resolution also requests that a copy be sent to the Office of the Surgeon General to support ongoing health education efforts.
The Maternal Vaccination Act amends the Public Health Service Act to expand a federal campaign focused on increasing vaccination rates among pregnant and postpartum individuals and their children. This legislation directly affects public health programs by updating language to explicitly include these populations and directing funding toward outreach efforts that address disparities among racial and ethnic minority groups. Key provisions modify existing sections of the Public Health Service Act to broaden the campaign's scope and increase the authorized funding amount from $15 million to $17 million per fiscal year for the period 2027 through 2031. The bill aims to improve vaccination equity by ensuring federal resources specifically target maternal and pediatric immunization efforts.
This bill requires Medicare Part D prescription drug plans to include certain lower-cost generic drugs and biosimilar biological products in preferred positions on their formularies starting in 2027. It mandates that these lower-cost alternatives be placed on more favorable tiers with reduced out-of-pocket costs compared to their brand-name counterparts. Additionally, the legislation prohibits plans from imposing stricter access restrictions, such as prior authorization or step therapy, on these lower-cost options than those applied to the original brand-name drugs. The measure directly affects Medicare beneficiaries enrolled in Part D plans and the insurance sponsors who manage those formularies.
This bill, known as the Prediction Market RISK Act, extends existing federal securities regulations to cover prediction markets, which are platforms where users trade contracts based on future events like elections or sports outcomes. It directly affects individuals and companies operating these trading platforms by bringing them under the enforcement authority of the Commodity Futures Trading Commission. The key provision applies rules that currently prohibit insider trading and other illegal practices to prediction market contracts, requiring these platforms to comply with the same standards as traditional financial markets. This change aims to increase oversight and prevent unfair trading advantages in the prediction market space.
This concurrent resolution formally recognizes the ongoing disparity between wages paid to men and women in the United States and reaffirms Congress's commitment to supporting equal pay. It highlights statistical data showing that women earn approximately 81 cents for every dollar earned by men, with significant variations across racial and ethnic groups, and notes that the gender wage gap has widened over the past two years. The document also identifies contributing factors such as occupational segregation, lack of family-friendly workplace policies, and workplace harassment, while emphasizing the economic impact on women's retirement security and family incomes.
This bill establishes a new annual wealth tax on individuals with net assets exceeding $50 million, effective in 2027, targeting ultra-wealthy taxpayers by taxing the total value of their taxable assets rather than income. The tax uses a tiered structure with a 0% bracket up to $50 million, a 2% rate between $50 million and $1 billion, and a 3% or 6% rate on assets above $1 billion, with the higher rate applying if a universal health insurance program is enacted. It includes special rules for married couples filing jointly, trusts, and non-resident aliens, while also adding stricter information reporting requirements and increased IRS funding for enforcement.
This bill, the End Polluter Welfare for Enhanced Oil Recovery Act of 2026, removes tax incentives for enhanced oil recovery projects that use carbon dioxide as an injectant. It directly affects oil and gas companies and energy producers who build qualified facilities after the law is enacted. The legislation eliminates the tax credit for carbon capture and storage when the captured carbon dioxide is used to extract more oil from existing wells. Additionally, the bill repeals the federal enhanced oil recovery tax credit that previously allowed companies to deduct certain costs related to extracting additional oil from mature wells. These changes apply to taxable years beginning after the bill is enacted.
This bill establishes a policy requiring Saudi Arabia to give up uranium enrichment and reprocessing capabilities on its soil and agree to an International Atomic Energy Agency inspection protocol before the U.S. can approve a civilian nuclear cooperation agreement with the country. It mandates that the President submit a detailed report to Congress outlining Saudi Arabia's commitments on these nuclear restrictions before any agreement can proceed. Additionally, the legislation requires Congress to pass a joint resolution explicitly approving the agreement before it can take effect, ensuring legislative oversight over the deal. The bill also directs the U.S. to oppose nuclear technology sales to Saudi Arabia through the Nuclear Suppliers Group until these conditions are met.
The STOP Corrupt Bets Act of 2026 prohibits trading on prediction markets related to political elections, government actions, sporting events, and military operations through registered financial entities. This ban applies to contracts, transactions, or swaps involving these topics unless they are used for legitimate hedging or commercial risk mitigation. The bill also directs the Comptroller General to conduct a study on prediction markets, focusing on insider trading, impacts on young adults, and ways to address illegal activities in both domestic and foreign markets. Additionally, the legislation clarifies that it does not override state laws regulating gambling.
This bill prohibits the use of federal funds for military force in or against Cuba from its enactment until December 31, 2026, unless Congress declares war or passes specific statutory authorization. The restriction applies to all government funds and prevents military actions without congressional approval under the War Powers Resolution. An exception allows military force consistent with the War Powers Resolution's provisions for urgent situations requiring immediate action. The legislation directly affects the U.S. Department of Defense and federal budget processes by limiting how funds can be used for military operations targeting Cuba.
HRES 971 is a non-binding resolution condemning China's economic and military actions against Japan following Japanese officials' comments about Taiwan. It specifically addresses China's travel advisory (causing $1.2 billion in tourism losses), a ban on Japanese seafood imports, and military drills near Japanese territory. The resolution reaffirms U.S. support for the U.S.-Japan alliance under their mutual security treaty and calls on China to cease coercion. It emphasizes U.S. commitment to upholding a "free and open Indo-Pacific" based on international law. This resolution directly affects Japan's economy and security, with no new legal obligations but serving as a formal U.S. policy statement.
HR 7653, the Biodefense Diplomacy Enhancement Act, requires the U.S. Secretary of State to develop two new strategies to strengthen international cooperation on biodefense, biosecurity, and biotechnology. The bill mandates a NATO Biodefense Strategy to improve alliance coordination on biological threat response and a broader International Cooperation Strategy to enhance partnerships with U.S. allies and major non-NATO partners on export controls for dual-use biotech items and adherence to safety standards. These strategies must identify gaps in current efforts, recommend improvements, and assess coordination with U.S. agencies, with reports due to Congress within 270 days of enactment. The bill directly affects U.S. diplomatic engagement with NATO and allied nations on biological threat preparedness, focusing on policy development, capabilities, and enforcement of the Biological Weapons Convention.
